Jump Trading’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Jump Trading’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-51	Closed	-$266K	–	914
2015 Q3	$266K	Buy	+51	New	+$342	﹤0.01%	317

Other funds holding KERX

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PIMJS

PKO Investment Management Joint-Stock Warsaw, Poland $1.38B AUM 59.54% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jump Trading's KERX Position: Q2 2018 in Review

Jump Trading sold out of Keryx Biopharmaceuticals Inc (KERX) in Q2 2018, closing a stake of 13,746 shares — an estimated $56K sold.

Jump Trading first reported a position in KERX in Q1 2018 and held it in 1 quarter. The position peaked at $56K in Q1 2018. 132 funds tracked by Wall St. Rank hold KERX as of Q2 2018.

Jump Trading reported no remaining Keryx Biopharmaceuticals Inc position as of Q2 2018 after selling out during the quarter.
Jump Trading sold 13,746 Keryx Biopharmaceuticals Inc shares in Q2 2018, an estimated $56K.
Jump Trading first reported a position in Keryx Biopharmaceuticals Inc in Q1 2018 and held it in 1 quarter.
Jump Trading's Keryx Biopharmaceuticals Inc position peaked at $56K in Q1 2018.
132 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q2 2018.

Based on Jump Trading's 13F filing for Q2 2018, filed 14 Aug 2018.